Gulf Coast TX
Factbox-US drugmakers turn to China for licensing deals
Sept 28 (Reuters) -- Merck on Monday agreed to pay Chinese biotech SciBrunch Therapeutics $400 million upfront for global rights to an experimental cancer drug, making it the lates…
